CANNABINOID COMPOSITIONS AND METHODS OF USING
개요
발명자
Elliot Altman; Matthew Fuller; Gheda Alsaif; Shannon Smith; Karen Maynard; Anthony Farone
IPC 분류
CPC 분류
This disclosure describes compositions including cannabinoids and methods of using those compositions including, for example, to treat or prevent inflammation, as an immunosuppressant, and/or as an anti-cancer therapeutic. In some aspects, the pharmaceutical composition comprises an approximately 1:1 equimolar mixture of CBD:CBDA In other aspects, the pharmaceutical composition comprises a cannabinoid; and an approximately 1:1 equimolar mixture of CBD:CBDA. The cannabinoid may comprise at least one of CBC, CBCA, CBD, CBDA, CBDV, CBDVA, CBG, CBGA, CBL, CBLA, CBN, CBNA, THCV, or THCVA.
원문 (중국어)
This disclosure describes compositions including cannabinoids and methods of using those compositions including, for example, to treat or prevent inflammation, as an immunosuppressant, and/or as an anti-cancer therapeutic. In some aspects, the pharmaceutical composition comprises an approximately 1:1 equimolar mixture of CBD:CBDA In other aspects, the pharmaceutical composition comprises a cannabinoid; and an approximately 1:1 equimolar mixture of CBD:CBDA. The cannabinoid may comprise at least one of CBC, CBCA, CBD, CBDA, CBDV, CBDVA, CBG, CBGA, CBL, CBLA, CBN, CBNA, THCV, or THCVA.